NICE said it made every effort to support reimbursement for Kisunla and Leqembi, but found the medicines are “not good value ...

Draig Therapeutics has secured £107m ($140m) in an oversubscribed Series A financing round to treat major neuropsychiatric ...

The FDA has approved Gilead Sciences' injectable product, Yeztugo (lenacapavir), as a pre-exposure prophylaxis (PrEP) against ...

Tisento Therapeutics has received fast track designation from the US Food and Drug Administration (FDA) for zagociguat.

Bavarian Nordic has sold a PRV for $160m, a day after the FDA announced a new scheme utilising the fast-track tickets.

NHS England chair Penny Dash shared her views on European healthcare during a fireside discussion at HLTH Europe in Amsterdam ...

Orion Corporation has broadened its partnership with Glykos, focusing on the development of antibody-drug conjugates (ADCs).

FDA Commissioner Dr Marty Makary tried to allay industry concerns about recent cuts and outlined his agenda for the future.

The FDA launched a new Priority Review program, as uncertainty persists for the existing programme for paediatric disorders.

India has proposed increasing US manufacturing by Indian pharma providers of APIs and the final stages of drug processing ...

Lisata Therapeutics has formed a strategic partnership with GATC Health for advancing AI-driven drug discovery and ...